STAT+: More hospitals are billing patients as online messages surge
Health systems drowning in messages from patients are grasping for new ways to manage the…
Category: finance
STAT+: Blue Cross Blue Shield insurers keep winning from Affordable Care Act’s risk program
A program that undergirds the Affordable Care Act’s health insurance marketplaces continues to bolster the…
Biden launches a new push to limit health care costs hoping to show he can save money for families
WASHINGTON (AP) — President Biden on Friday rolled out a new set of initiatives to…
STAT+: Bright Health sells Medicare Advantage plans to Molina for $600 million
Bright Health Group has agreed to sell its Medicare Advantage plans to its publicly traded…
STAT+: With Wegovy and Ozempic’s success, can device makers keep up in the race to treat obesity?
The makers of minimally invasive surgical devices seemed poised to capture a wide swath of…
STAT+: UnitedHealth wins $3.3 billion takeover of home health giant Amedisys
Home health and hospice chain Amedisys has chosen a new corporate owner. Amedisys and UnitedHealth…
STAT+: How drug pricing reforms are affecting Bayer’s investments
WASHINGTON — Pharma companies have long been warning Democrats’ drug pricing reforms could discourage investment in…
STAT+: Health insurance stocks tumble after UnitedHealth says Medicare enrollees are getting more care
A top executive at UnitedHealth Group said Tuesday that the health insurance and services conglomerate…
STAT+: Bitter infighting leads 15 chapters to break away from leading ALS advocacy group
After a bitter dispute, the ALS Association has settled a lawsuit filed by 15 chapters…
STAT+: Top Senate Republican signals interest in site-neutral reform for hospitals
WASHINGTON — A top Senate Republican signaled his interest in pursuing hospital payment reform to…
STAT+: UnitedHealth starts bidding war with $3.3 billion offer for Amedisys
There’s now a two-party showdown for one of the largest home health companies in the…
STAT+: How Blue Cross Blue Shield insurers ratcheted up profits in 2022
A $203 million tax refund for Blue Cross Blue Shield of North Carolina. Nearly $1.5…
STAT+: Coherus works with Mark Cuban to sell biosimilar Humira at steep discounts
In a bold move, Coherus BioSciences plans to sell a biosimilar version of Humira —…
STAT+: Boston Scientific cancels $230 million deal to buy Korean device company
Boston Scientific is scrapping its $230 million plan to buy a majority stake in M.I….
STAT+: Seagen criticized by shareholder advisory firm for ‘problematic’ executive compensation ahead of Pfizer acquisition
As Seagen prepares to be acquired by Pfizer, an investor advisory firm is raising concerns…
STAT+: Envision Healthcare files for bankruptcy
Physician staffing firm Envision Healthcare officially filed for Chapter 11 bankruptcy on Monday, a move…
STAT+: In Silicon Valley, a venture capital firm gives health tech startups a crash course in getting paid
REDWOOD CITY, Calif. — Over two blustery spring days earlier this month, 30 hopeful tech…
.jpg)
STAT+: Hospital-insurer tussle in Arizona puts care denials front and center
UnitedHealthcare and Phoenix Children’s Hospital are embroiled in a bitter contract dispute that would lock…
STAT+: Wyden decries ‘astonishingly low’ tax rates for pharma companies as he probes business maneuvers
Thanks to changes in tax law six years ago, several of the largest pharmaceutical companies…
Gail Wilensky on the Geisinger deal, the earnings bonanza, and medical credit cards proliferate
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Geisinger board member: Local consolidation influenced Kaiser-Geisinger deal
A long-running flurry of hospital and medical group acquisitions in Pennsylvania — especially among the…
STAT+: Option Care takes over Amedisys in ‘perplexing’ $3.6 billion home care deal
Option Care Health is buying Amedisys in an all-stock merger valued at $3.6 billion, creating…
STAT+: Vinod Khosla predicts AI doctors could be here sooner than you think
Sun Microsystems co-founder Vinod Khosla is famous for predictions that have helped usher in the…
STAT+: New mega-deal highlights Geisinger’s fall, and raises concerns about where Kaiser is going next
In 2009, when President Barack Obama was touring the country and ginning up support for…
STAT+: Once bullish on digital health, Orexo hits a wall on reimbursement
After several quarters of promising to deliver concrete progress on key digital therapeutics projects, Swedish…
GoodRx hires former tech exec as CEO, Amazon shutters Halo, and Teladoc beats expectations
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Health insurance CEOs set another record for pay in 2022
Business has never been better for the largest health insurers in the country, which led…
STAT+: Kaiser Permanente, Geisinger to merge into national health system
Kaiser Permanente and Geisinger have agreed to combine into a new national not-for-profit system that…
STAT+: RNA startup Orbital cinches $270 million investment
A new biotech founded by veterans of Alnylam Pharmaceuticals, Beam Therapeutics, ARCH Venture Partners, and…
STAT+: How a small hospital in Nebraska has thrived through the pandemic
Great Plains Health is a small hospital system in a part of Nebraska surrounded by…
STAT+: HCA bags big first quarter as patient volumes soar
Patient volumes are back in a big way, at least for the country’s largest for-profit…
STAT+: HCA, Louisiana hospital system sue FTC over review of hospital deal
HCA Healthcare and LCMC Health each sued the Federal Trade Commission and Department of Justice…
STAT+: Mindpath seemed like a success story for private equity in mental health. Now, it’s a cautionary tale
As a Covid-driven mental health crisis enveloped the U.S. in 2020, two private equity firms…
STAT+: Define Ventures raises $460 million to fuel early-stage health tech startups
At a challenging time for digital health startups, Define Ventures announced on Tuesday it has…
STAT+: From a public library whiteboard, a $350 million biotech venture fund
A new biotech VC firm started by veterans of the industry began around a whiteboard…
STAT+: Oscar Health names former Aetna executive as new CEO
The tech-forward insurer Oscar Health has tapped former Aetna CEO Mark Bertolini to be its…
Opinion: The lesson biotech absolutely should not take from Silicon Valley Bank’s failure
As a five-time biotech CEO, I’ve guided my companies through recessions, supply chain disruptions, Wall…
STAT+: Moderna CEO made $398 million in 2022, but still pledges to give most to charity
Moderna CEO Stéphane Bancel is starting to reap gargantuan gains from the stock he first…
STAT+: 102 hours of chaos: How SVB’s collapse rattled the biotech industry
Paul Rennert was surprisingly energized after deplaning a transatlantic flight in Boston Thursday evening. He…
STAT+: SVB, biotech’s bank of choice, just failed. It could have ripple effects
Silicon Valley Bank, which does business with roughly half of the nation’s tech and biotech…
STAT+: Medicare will take R&D costs, effectiveness into account when it negotiates drug prices. But studies show that doesn’t affect prices
By law, Medicare will have to take a medication’s efficacy and its research and development…
Listen: Pharma blockbusters, pandemic policy, & legal chicanery
Is the next Lipitor on the way? When is a pandemic over-over? And what’s a…
STAT+: KKR veteran sets records with $3.9 billion health care fund
The former head of health care investing at private equity giant KKR has set records…
STAT+: Alphabet’s laid-off health tech employees on where their work heads next
Big Tech has gone through a rough stretch of layoffs — between Meta, Amazon, Alphabet,…
STAT+: Focused exclusively on life sciences, three top investors set out on their own
Almost a year ago, three top investors at Lux Capital and Obvious Ventures announced they…
STAT+: A different kind of ‘RAC’ subsidized hospitals’ labor during the pandemic
Hospitals have bemoaned rising employee expenses throughout the pandemic, as they’ve paid workers more to…
STAT+: How one private biotech seized on JPM to emerge from stealth and tell its story
SAN FRANCISCO — The team behind Rezo Therapeutics, a new biotech co-founded by a group…
STAT+: Hospitals gear up to expand market power, raise prices in 2023
SAN FRANCISCO — More than a dozen of the country’s large not-for-profit hospital systems descended…
STAT+: Biotech startups are hungry for dollars. Here’s what one pharma executive was looking for at JPM
Marianne De Backer’s iPhone calendar is a solid block of green. De Backer, the head…
STAT+: Medicare paves the way for CAR-T in doctors offices
WASHINGTON — Medicare officials have taken a step toward making a cutting-edge cancer treatment called…